p53 Immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status

Modern Pathology

Volumn 12, Issue 1, 1999, Pages 54-60

  Tolbert, Dawn M ^a   Noffsinger, Amy E ^a   Miller, Mary A ^a   DeVoe, Gary W ^a   Stemmermann, Grant N ^a   Macdonald, John S ^b   Fenoglio Preiser, Cecilia M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b ST VINCENT S COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

Immunohistochemistry; Mutation; P53; SSCP

Indexed keywords

PROTEIN P53;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EXON; GENE INSERTION; GENE MUTATION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRODUCIBILITY; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; STAINING; STOMACH CANCER; STOP CODON; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; DNA, SINGLE-STRANDED; FORECASTING; GENE FREQUENCY; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR CONFORMATION; MUTATION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032940143     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-11.
2. Lane DP. p53: guardian of the genome. Nature 1992;358: 15-6.
3. Levine AJ. The p53 tumor-suppressor gene. N Engl J Med 1992;326:1350-2.
4. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates cytotoxicity of anticancer agents. Cell 1993;74:957-67.
5. Suzuki Y, Sekiya T, Hayashi K. Allele-specific polymerase chain reaction: a method for amplification and sequence determination of a single component among a mixture of sequence variants. Anal Biochem 1991;192:82-4.
6. Motojima K, Furui J, Kohara N, Ito T, Kanematsu T. Expression of p53 protein in gastric carcinomas is not independently prognostic. Surgery 1994;116:890-5.
7. Martin HM, Filipe MI, Morris RW, Lane DP, Silvestre F. p53 expression and prognosis in gastric carcinoma. Int J Cancer 1992;50:859-62.
8. Uchino S, Noguchi M, Hirota T, Itabashi M, Saito T, Kobayashi M, et al. High incidence of nuclear accumulation of p53 protein in gastric cancer. Jap J Clin Oncol 1992;22:225-31.
9. Kakeji Y, Korenaga D, Tsujitani S, Baba H, Anai H, Maehara Y, et al. Gastric cancer with p53 overexpression has high potential for metastasizing to lymph nodes. Br J Cancer 1993;67:589-93.
10. Shiao YH, Rugge M, Correa P, Lehmann HP, Scheer WD. p53 alteration in gastric precancerous lesions. Am J Pathol 1994; 144:511-7.
11. Imazeki F, Omata M, Nose H, Ohto M, Isono K. p53 gene mutations in gastric and esophageal cancers. Gastroenterology 1992:103:892-6.
12. Yokozaki H, Kuniyasu H, Kitadai Y, Nishimura K, Todo H, Ayhan A, et al. p53 point mutations in primary human gastric carcinomas. J Cancer Res Clin Oncol 1992;119:67-70.
13. Matozaki T, Sakamoto C, Suzuki T, Matsuda K, Uchida T, Nakano O, et al. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cell. Cancer Res 1992;52:4335-41.
14. Sano T, Tsujino T, Yoshida K, Nakayama H, Haruma K, Ito H, et al. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Cancer Res 1991; 51:2926-31.
15. McKee PH, Hobbs C, Hall PA. Antigen retrieval by microwave irradiation lowers immunohistological detection thresholds. Histopathology 1993;23:377-9.
16. Lambkin HA, Mothersill CM, Kelehan P. Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection. J Pathol 1994;172:13-8.
17. Baas IO, Mulder JWR, Offerhaus GJA, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994;172:5-12.
18. Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, Hirohashi S. p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer 1993;54:759-64.
19. Hartmann A, Blaszyk H, McGovern RM, Shroeder JJ, Cunningham J, DeVries EMG, et al. p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers. Oncogene 1995;10:681-8.
20. Hayashi K. PCR-SSCP: a method for detection of mutations. Genet Anal Tech Appl 1992;9:73-9.
21. Spagnolo DV, Turbett GR, Dix B, Iacopetta B. Polymerase chain reaction and single-strand conformation polymorphism analysis (PCR-SSCP): a novel means of detecting DNA mutations. Adv Anat Pathol 1994;1:61-77.